๐Ÿ”ฅ๐Ÿ” BizChicken ๐Ÿ”๐Ÿ”ฅ

Companies Similar to Sana Biotechnology, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

BioAtla, Inc.

BioAtla, Inc. logo
Market Cap: Low
Employees: Low

BA3011

Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.

Tags: antibody-based therapeutics, biopharmaceutical, cancer, clinical stage, solid tumor

Symbol: BCAB

Recent Price: $0.59

Industry: Biotechnology

CEO: Dr. Jay M. Short Ph.D.

Sector: Healthcare

Employees: 65

Address: 11085 Torreyana Road, San Diego, CA 92121

Phone: 858 558 0708

Last updated: 2024-12-31

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. logo
Market Cap: Highest
Employees: Medium

ENHANZE drug delivery technology

Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.

Tags: ENHANZE, biologics, biopharma, drug delivery, technology, therapeutics

Symbol: HALO

Recent Price: $47.99

Industry: Biotechnology

CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.

Sector: Healthcare

Employees: 373

Address: 11388 Sorrento Valley Road, San Diego, CA 92121

Phone: 858 794 8889

Last updated: 2024-12-31

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cell-in-a-Box

Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.

Tags: Cell-in-a-Box, biotechnology, cancer, cannabis plant, cellular therapies, diabetes, insulin-dependent diabetes, live cell encapsulation, pancreatic cancer

Symbol: PMCB

Recent Price: $1.55

Industry: Biotechnology

CEO: Mr. Joshua N. Silverman

Sector: Healthcare

Employees: 2

Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Phone: 917 595 2850

Leadership

  • Joshua N. Silverman, Independent Director
  • Dr. Michael M. Abecassis, Independent Director
  • Robert Weinstein, Director
  • Wayne R. Walker, Director
  • Jonathan L. Schechter, Independent Director
  • Dr. Abecassis, Director
  • Kenneth L. Waggoner, Independent Director
  • Daniel C. Farb, Independent Director
  • Daniel C. Allen, Independent Director
  • Jack E. Stover, Independent Director

Last updated: 2024-12-31

Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

TN-201, TN-301, TN-401

Tenaya Therapeutics, Inc. is a biotechnology company that discovers, develops, and delivers therapies for heart disease using cellular regeneration, gene therapy, and precision medicine platforms.

Tags: biotechnology, gene therapy, heart disease, precision medicine, therapeutics

Symbol: TNYA

Recent Price: $1.45

Industry: Biotechnology

CEO: Mr. Faraz Ali M.B.A.

Sector: Healthcare

Employees: 140

Address: 171 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 825 6900

Last updated: 2024-12-31

bluebird bio, Inc.

bluebird bio, Inc. logo
Market Cap: Low
Employees: Medium

betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel

bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for รŸ-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.

Tags: betibeglogene autotemcel, biotechnology, elivaldogene autotemcel, gene therapy, genetic diseases, lovotibeglogene autotemcel

Symbol: BLUE

Recent Price: $7.86

Industry: Biotechnology

CEO: Mr. Andrew Obenshain

Sector: Healthcare

Employees: 375

Address: 60 Binney Street, Cambridge, MA 02142

Phone: 339 499 9300

Leadership

  • Sarah Alspach, Senior Vice President, External Affairs
  • Rich Colvin, MD, PhD, Chief Medical Officer
  • Kasra Kasraian, Senior Vice President, Technical Development and Operations
  • Tom Klima, Chief Commercial & Operating Officer
  • Andrew Obenshain, Chief Executive Officer
  • Scott Shoemaker, Senior Vice President, Quality
  • James Sterling, Chief Financial Officer
  • Joe Vittiglio, Chief Business and Legal Officer
  • Andrea Walton, Chief People Officer
  • Leslie Wilder, Vice President, Head of Regulatory Science
  • Mark Vachon, Chairman; Formerly of GE
  • John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
  • Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
  • Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
  • Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
  • Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
  • Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
  • Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

DAY101

Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for genetically defined cancers. Their lead product candidate is DAY101, currently in Phase II clinical trials for pediatric patients with low-grade glioma.

Tags: DAY101, Pimasertib, biopharmaceuticals, cancer therapy, clinical-stage

Symbol: DAWN

Recent Price: $12.58

Industry: Biotechnology

CEO: Dr. Jeremy Bender M.B.A., Ph.D.

Sector: Healthcare

Employees: 174

Address: 395 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 484 0899

Leadership

  • Samuel Blackman, MD, PhD, Head of R&D
  • Elly Barry, MD, Chief Medical Officer
  • Jeremy Bender, PhD, MBA, Director
  • Davy Chiodin, PharmD, Chief Development Officer
  • Adam Dubow, General Counsel
  • Lauren Merendino, MBA, Chief Commercial Officer
  • John Stubenrauch, Chief Technology Officer
  • Jaa Roberson, Chief People Officer
  • Charles N. York II, MBA, Chief Operating and Financial Officer
  • Garry Nicholson, MBA, Chair
  • Habib Dable, Director
  • Scott Garland, Director
  • Michael Gladstone, Director
  • William Grossman, MD, PhD, Director
  • Natalie Holles, Director
  • John A. Josey, PhD, MBA, Director
  • Saira Ramasastry, MS, MPhil, Director

Last updated: 2024-12-31

Harvard Bioscience, Inc.

Harvard Bioscience, Inc. logo
Market Cap: Low
Employees: Medium

cellular and molecular technology instruments

Harvard Bioscience, Inc. develops, manufactures, and sells technologies and services that support research, discovery, and pre-clinical testing for drug development globally, offering a wide range of instruments for tissue and organ-based lab research.

Tags: biotech, drug development, laboratory instruments, precision measuring, research

Symbol: HBIO

Recent Price: $2.02

Industry: Medical - Instruments & Supplies

CEO: Mr. James W. Green

Sector: Healthcare

Employees: 391

Address: 84 October Hill Road, Holliston, MA 01746

Phone: 508 893 8999

Leadership

  • James Green, Chairman, President & Chief Executive Officer
  • Jennifer Cote, Chief Financial Officer and Treasurer
  • John Fry, Chief Legal Counsel and Corporation Secretary
  • Diane Houston, Vice President, Global IT
  • Lori Packer, Vice President, Global People Operations
  • Nitya Shetty, Vice President, Global Research and Development
  • Ryan Wallace, Senior Vice President, Global Sales

Last updated: 2024-12-31

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANA001

A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.

Tags: biotechnology, cardiometabolic diseases, clinical trials, infectious diseases, neurodegenerative diseases

Symbol: NRBO

Recent Price: $2.36

Industry: Biotechnology

CEO: Mr. Hyung-Heon Kim

Sector: Healthcare

Employees: 8

Address: 200 Berkeley Street, Boston, MA 02116

Phone: 857 702 9600

Last updated: 2024-12-31

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

SAB-185, SAB-176

SAB Biotherapeutics is a clinical-stage biopharmaceutical company focusing on developing immunotherapies based on human antibodies, using advanced genetic engineering to produce fully-human polyclonal antibodies targeting diseases such as COVID-19, influenza, autoimmune disorders, and cancer.

Tags: COVID-19, autoimmune disorders, biopharmaceutical, cancer, human antibodies, immunotherapy, influenza

Symbol: SABS

Recent Price: $4.15

Industry: Biotechnology

CEO: Mr. Samuel J. Reich

Sector: Healthcare

Employees: 57

Address: 2100 East 54th Street North, Sioux Falls, SD 57104

Phone: 605 679 6980

Last updated: 2024-12-31

Sana Biotechnology, Inc.

Sana Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

N/A

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.

Tags: biotechnology, cell engineering, genetic disorders, medicine, oncology

Symbol: SANA

Recent Price: $1.61

Industry: Biotechnology

CEO: Dr. Steven D. Harr M.D.

Sector: Healthcare

Employees: 328

Address: 188 East Blaine Street, Seattle, WA 98102

Phone: 206 701 7914

Last updated: 2024-12-31

Sanara MedTech Inc.

Sanara MedTech Inc. logo
Market Cap: Low
Employees: Low

Cellerate RX, Biakoยฏs, HYCOL, FORTIFY TRG

Sanara Med Tech Inc. develops, markets, and distributes wound and skin care products, offering solutions like Cellerate RX, Biakoยฏs, and HYCOL to promote healing in various medical settings.

Tags: biofilm, collagen, healing, hospitals, medical products, skin care, wound care

Symbol: SMTI

Recent Price: $33.19

Industry: Medical - Instruments & Supplies

CEO: Mr. Ronald T. Nixon

Sector: Healthcare

Employees: 107

Address: 1200 Summit Avenue, Fort Worth, TX 76102

Phone: 817 529 2300

Leadership

  • Ron Nixon, Chairman
  • James W. (Jim) Stuckert, Director
  • Ann Beal Salamone, M.S., Director
  • Bob DeSutter, Director
  • Sara N. Ortwein, Director
  • Roszell Mack III, Director
  • Eric D. Tanzberger, Director
  • Eric Major, Director

Last updated: 2024-12-31

Bio-Techne Corporation

Bio-Techne Corporation logo
Market Cap: Highest
Employees: High

Life Science Reagents, Instruments, and Services

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for research and clinical diagnostics globally, operating through segments like Protein Sciences and Diagnostics and Genomics.

Tags: Diagnostics, Genomics, Instruments, Life Science, Protein Sciences, Reagents

Symbol: TECH

Recent Price: $72.29

Industry: Biotechnology

CEO: Mr. Kim Kelderman

Sector: Healthcare

Employees: 3100

Address: 614 McKinley Place N.E., Minneapolis, MN 55413

Phone: 612 379 8854

Last updated: 2024-12-31

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111

Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.

Tags: COVID-19, HIV, biotechnology, hepatitis B, immunology, infectious diseases, influenza, therapeutics

Symbol: VIR

Recent Price: $7.33

Industry: Biotechnology

CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

Sector: Healthcare

Employees: 587

Address: 499 Illinois Street, San Francisco, CA 94158

Phone: 415 906 4324

Leadership

  • Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
  • Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
  • Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
  • Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
  • Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
  • Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
  • Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
  • Jason Oโ€™Byrne, MBA, Executive Vice President and Chief Financial Officer
  • Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
  • Arran Attridge, Senior Vice President Corporate Communications
  • Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
  • Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow

Last updated: 2024-12-31

Zura Bio Limited

Zura Bio Limited logo
Market Cap: Low
Employees: Lowest

ZB-168

Zura Bio Limited is a clinical-stage biotechnology company based in San Diego, California, focusing on developing novel medicines for immune and inflammatory disorders.

Tags: biotechnology, clinical-stage, immune disorders, inflammatory disorders, novel medicines

Symbol: ZURA

Recent Price: $2.55

Industry: Biotechnology

CEO: Mr. Robert Lisicki

Sector: Healthcare

Employees: 14

Address: 4225 Executive Square, San Diego, CA 92037

Phone: 858 247 0520

Last updated: 2024-12-31

Abeona Therapeutics Inc.

Abeona Therapeutics Inc. logo
Market Cap: Low
Employees: Low

EB-101

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.

Tags: EB-101, biopharmaceutical, cell therapy, clinical trials, gene therapy, rare genetic diseases

Symbol: ABEO

Recent Price: $5.61

Industry: Biotechnology

CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.

Sector: Healthcare

Employees: 84

Address: 1330 Avenue of the Americas, New York, NY 10019

Phone: 646 813 4701

Last updated: 2024-12-31

Bionano Genomics, Inc.

Bionano Genomics, Inc. logo
Market Cap: Lowest
Employees: Medium

Saphyr

Bionano Genomics, Inc. provides genome analysis software solutions, including Saphyr for structural variation analysis by optical genome mapping, Nx Clinical for genomic variant interpretation, and laboratory services like First Step Dx PLUS for autism spectrum disorder.

Tags: cytogenetics, genetic variation, genome analysis, molecular genetics, optical genome mapping

Symbol: BNGO

Recent Price: $0.29

Industry: Medical - Diagnostics & Research

CEO: Dr. Robert Erik Holmlin M.B.A., Ph.D.

Sector: Healthcare

Employees: 344

Address: 9540 Towne Centre Drive, San Diego, CA 92121

Phone: 858 888 7600

Last updated: 2024-12-31

Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

N/A

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.

Tags: SARS-Co V-2, biotechnology, hepatitis B virus, liver diseases, pharmaceuticals, respiratory syncytial virus, small molecule drugs, viral infections

Symbol: ENTA

Recent Price: $5.85

Industry: Biotechnology

CEO: Dr. Jay R. Luly Ph.D.

Sector: Healthcare

Employees: 145

Address: 500 Arsenal Street, Watertown, MA 02472

Phone: 617 607 0800

Leadership

  • Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
  • Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
  • Matthew P. Kowalsky, J.D., Chief Legal Officer
  • Brendan Luu, Chief Business Officer
  • Paul J. Mellett, Chief Financial and Administrative Officer
  • Yat Sun Or, Ph.D., Chief Scientific Officer
  • Scott T. Rottinghaus, M.D., Chief Medical Officer
  • Bruce L.A. Carter, Ph.D., Chairman of the Board
  • Mark G. Foletta, Board Member
  • Yujiro S. Hata, Board Member
  • Kristine Peterson, Board Member
  • Lesley Russell, MBChB, MRCPb, Board Member
  • Terry Vance, Board Member

Last updated: 2024-12-31

IN8bio, Inc.

IN8bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

INB-200, INB-100, INB-400, INB-300

IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.

Tags: biopharmaceutical, biotechnology, cancer treatment, clinical trials, gamma-delta T cell therapies

Symbol: INAB

Recent Price: $0.27

Industry: Biotechnology

CEO: Mr. Tai-Wei Ho

Sector: Healthcare

Employees: 39

Address: 350 5th Avenue, New York, NY 10118

Phone: 646 600 6438

Last updated: 2024-12-31